Breakthrough Therapy — What It Means in Clinical Trials
Plain English Definition
Breakthrough therapy is a special FDA designation for drugs that show early evidence of substantial improvement over existing treatments for serious conditions. This designation speeds up the development and review process. It does not mean the drug is approved — it means the FDA will work closely with the company to expedite its path to approval.
Why It Matters
If a trial drug has breakthrough therapy designation, it means early results were exceptionally promising. This can be encouraging, but remember that not all breakthrough-designated drugs ultimately get approved.
Example
A press release might say: "Drug Y received FDA Breakthrough Therapy Designation for treatment-resistant depression based on Phase 2 data."
Need help understanding eligibility criteria?
How to Read Eligibility Criteria →